Home/Filings/4/0001493152-20-023583
4//SEC Filing

Levine Mitchell S 4

Accession 0001493152-20-023583

CIK 0001642380other

Filed

Dec 14, 7:00 PM ET

Accepted

Dec 15, 6:13 AM ET

Size

4.7 KB

Accession

0001493152-20-023583

Insider Transaction Report

Form 4
Period: 2020-12-11
Levine Mitchell S
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2020-12-11+10,12146,700 total
Footnotes (1)
  • [F1]The shares of the Issuer's common stock were issued to the Reporting Person for the repayment of deferred compensation in lieu of cash at a price of $2.07 per share.

Documents

1 file

Issuer

OncoCyte Corp

CIK 0001642380

Entity typeother

Related Parties

1
  • filerCIK 0001383492

Filing Metadata

Form type
4
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 6:13 AM ET
Size
4.7 KB